Medical approaches in the management of prostatic disease

[1] THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J]. PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) : 373 - 380

[2] BAILAR JC, 1970, CANCER, V26, P257, DOI 10.1002/1097-0142(197008)26:2<257::AID-CNCR2820260203>3.0.CO

[3] 2-9

[4] THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J]. JOURNAL OF UROLOGY, 1984, 132 (03) : 474 - 479

[5] CAHEN RJ, 1990, BR J UROL, V66, P405

[6] Coffey D.S., 1992, CAMPBELLS UROLOGY, P221

[7] COLOMBEL M, 1993, AM J PATHOL, V143, P390

[8] A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) : 419 - 424

[9] CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559

[10] DAWSON NA, 1996, COMPREHENSIVE TXB GE, P907

[1] THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J]. PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) : 373 - 380

[2] BAILAR JC, 1970, CANCER, V26, P257, DOI 10.1002/1097-0142(197008)26:2<257::AID-CNCR2820260203>3.0.CO

[3] 2-9

[4] THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J]. JOURNAL OF UROLOGY, 1984, 132 (03) : 474 - 479

[5] CAHEN RJ, 1990, BR J UROL, V66, P405

[6] Coffey D.S., 1992, CAMPBELLS UROLOGY, P221

[7] COLOMBEL M, 1993, AM J PATHOL, V143, P390

[8] A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (07) : 419 - 424

[9] CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559

[10] DAWSON NA, 1996, COMPREHENSIVE TXB GE, P907